Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Gilbert

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|October 21, 2014
Lanreotide delays progression of neuroendocrine tumoursJudith A Gilbert
The Lancet. Oncology|March 1, 2016
Overuse of PET to monitor lung or oesophageal cancersJudith A Gilbert
The Lancet. Oncology|June 20, 2017
Alectinib surpasses crizotinib for untreated ALK-positive NSCLCJudith A Gilbert
The Lancet. Respiratory Medicine|March 26, 2017
Nosocomial nontuberculous mycobacteria infections associated with heater-cooler devicesJudith A Gilbert
The Lancet. Microbe|May 11, 2022
Microbiome therapy for recurrent Clostridioides difficileJudith A Gilbert
The Lancet. Respiratory Medicine|August 29, 2018
Sepsis care bundles: a work in progressJudith A Gilbert
The Lancet. Oncology|August 23, 2017
Ready-to-use T cells for infection after stem-cell transplantJudith A Gilbert
The Lancet. Respiratory Medicine|March 21, 2018
Effect of increasing glucocorticoids on asthma exacerbationsJudith A Gilbert
The Lancet. Oncology|February 13, 2018
CAR T-cells for relapsed B-cell ALL in adultsJudith A Gilbert
The Lancet. Diabetes & Endocrinology|November 8, 2016
Neuroendocrine tumours emerge from the shadowsJudith A Gilbert
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|October 21, 2014
Lanreotide delays progression of neuroendocrine tumoursJudith A Gilbert
The Lancet. Oncology|March 1, 2016
Overuse of PET to monitor lung or oesophageal cancersJudith A Gilbert
The Lancet. Oncology|June 20, 2017
Alectinib surpasses crizotinib for untreated ALK-positive NSCLCJudith A Gilbert
The Lancet. Respiratory Medicine|March 26, 2017
Nosocomial nontuberculous mycobacteria infections associated with heater-cooler devicesJudith A Gilbert
The Lancet. Microbe|May 11, 2022
Microbiome therapy for recurrent Clostridioides difficileJudith A Gilbert
The Lancet. Respiratory Medicine|August 29, 2018
Sepsis care bundles: a work in progressJudith A Gilbert
The Lancet. Oncology|August 23, 2017
Ready-to-use T cells for infection after stem-cell transplantJudith A Gilbert
The Lancet. Respiratory Medicine|March 21, 2018
Effect of increasing glucocorticoids on asthma exacerbationsJudith A Gilbert
The Lancet. Oncology|February 13, 2018
CAR T-cells for relapsed B-cell ALL in adultsJudith A Gilbert
The Lancet. Diabetes & Endocrinology|November 8, 2016
Neuroendocrine tumours emerge from the shadowsJudith A Gilbert
Pageof 5